ViewRay registers for an initial public offering worth up to $69 million for its MRIdian cancer detection and radiation treatment device.
ViewRay last week said it plans to raise up to $69 million in an initial public offering for its MRIdian system, which it bills as "the 1st and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously."
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1MqHyZE
Cap comentari:
Publica un comentari a l'entrada